Search

Your search keyword '"Brown, Wv"' showing total 378 results

Search Constraints

Start Over You searched for: Author "Brown, Wv" Remove constraint Author: "Brown, Wv"
378 results on '"Brown, Wv"'

Search Results

1. Evolocumab and clinical outcomes in patients with cardiovascular disease

2. Evolocumab and clinical outcomes in patients with cardiovascular disease

3. From the Editor-in-Chief

4. Impact of Dyslipidaemia

5. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

6. When do we treat hypercholesterolemia?

7. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient

8. Clinical trials including an update on the Helsinki heart study

9. Varespladib and cardiovascular events in patients with an acute coronary syndrome: The VISTA-16 randomized clinical trial

10. From the Editor

17. Pharmacological treatment of lipid disorders in diabetes.

18. Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia [corrected] [published erratum appears in AM J CLIN NUTR 2000 Oct; 72(4): 1066].

19. Incorporation of Sialic Acid into Sialidase-Treated Apolipoprotein of Human, Very Low Density Lipoprotein by a Pork Liver Sialyltransferase

20. Preventive strategies for reducing coronary heart disease-related morbidity and mortality in patients with multiple risk factors

21. Glucose Homeostasis in Viral Hepatitis

22. Defensive alkaloids of Cryptolaemus montrouzieri (Coleoptera : Coccinellidae)

23. The chemistry of the metasternal gland secretion of the eucalypt longicorn Phoracantha synonyma (Coleoptera : Cerambycidae)

25. Identity of Very Low Density Lipoprotein Apoproteins of Plasma and Liver Golgi Apparatus

26. Chemistry of the metasternal gland secretion of the common eucalypt longicorn, phoracantha semipunctata(coleoptera: cerambycidae)

27. Further characterization of the apolipoproteins of rat plasma lipoproteins

34. Metabolic syndrome and risk of stroke.

35. What are the priorities for managing cholesterol effectively?

36. Novel approaches to lipid lowering: what is on the horizon?

39. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.

41. Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.

42. Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized Therapy.

43. Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management.

44. Roundtable on etiology of familial chylomicronemia syndrome.

47. JCL roundtable: Future of the lipid laboratory: Using the laboratory to manage the patient (part 2).

48. Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

Catalog

Books, media, physical & digital resources